These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25375228)

  • 1. Weight loss in nonalcoholic Fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits.
    Dudekula A; Rachakonda V; Shaik B; Behari J
    PLoS One; 2014; 9(11):e111808. PubMed ID: 25375228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
    Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
    Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
    Du T; Yu X; Yuan G; Zhang J; Sun X
    Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a multidisciplinary weight loss intervention in overweight and obese children and adolescents: 11 years of experience.
    Mameli C; Krakauer JC; Krakauer NY; Bosetti A; Ferrari CM; Schneider L; Borsani B; Arrigoni S; Pendezza E; Zuccotti GV
    PLoS One; 2017; 12(7):e0181095. PubMed ID: 28704494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease.
    Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e529-e534. PubMed ID: 33867441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment.
    Koot BG; van der Baan-Slootweg OH; Vinke S; Bohte AE; Tamminga-Smeulders CL; Jansen PL; Stoker J; Benninga MA
    Int J Obes (Lond); 2016 Jan; 40(1):51-7. PubMed ID: 26315844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.
    VanWagner LB; Khan SS; Ning H; Siddique J; Lewis CE; Carr JJ; Vos MB; Speliotes E; Terrault NA; Rinella ME; Lloyd-Jones DM; Allen NB
    Liver Int; 2018 Apr; 38(4):706-714. PubMed ID: 28963767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease].
    Fan JG; Zhou Q; Wo QH
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):676-9. PubMed ID: 20943079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of NAFLD With Diabetes and the Impact of BMI Changes: A 5-Year Cohort Study Based on 18,507 Elderly.
    Liu M; Wang J; Zeng J; Cao X; He Y
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1309-1316. PubMed ID: 28324002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models.
    Stewart KE; Haller DL; Sargeant C; Levenson JL; Puri P; Sanyal AJ
    Liver Int; 2015 Mar; 35(3):936-43. PubMed ID: 24521540
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sakamoto Y; Oniki K; Kumagae N; Morita K; Otake K; Ogata Y; Saruwatari J
    Dis Markers; 2019; 2019():4065327. PubMed ID: 31929840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.